Pharmaceutical

STAT+: Verily hires former Apple Health leader Andrew T...

As Verily aims to get on track, it has hired Andrew Trister, an oncologist and f...

Amazon expands telehealth clinic nationwide

In the latest edition of STAT's Health Tech newsletter: how YC's only health par...

STAT+: Microsoft strikes partnership with Duke Health t...

“We believe that every one of our clients and our partners need to be starting t...

STAT+: EQRx, failed developer of low-priced cancer drug...

EQRx, the once-buzzy, but now dormant biotech company, is being acquired by Revo...

STAT+: Pharmalittle: Medicare looks to improve Alzheime...

Medicare announced a pilot program aimed at improving dementia care , but it doe...

STAT+: How Y Combinator’s only health care partner deci...

It seems like every young tech company is vying for a coveted place in the Silic...

Cannabis industry scales back its lobbying in Washington

The cannabis industry is dramatically scaling back its presence in Washington.

Opinion: I learned the hard way that U.S. airlines are ...

Since 2016, airlines have been able to apply for “emergency” exemptions to the r...

Opinion: The airline industry needs some disaster manag...

People like to say health care should be more like the airline industry. This su...

Primary care physicians are learning how to fill the ga...

"We make gender-affirming care specialty care, and that automatically creates ba...

STAT+: Flow Neuroscience shows promising results in tri...

Flow is seeking FDA approval of its headset device, which uses transcranial dire...

STAT+: Medicare wants to improve Alzheimer’s care, but ...

Medicare wants to improve dementia care and reduce the strain on unpaid caregive...

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’...

Presidential candidate Vivek Ramaswamy recently posted a video trading on his bi...

NIH begins long-delayed clinical trials for long Covid,...

One trial involving Paxlovid is already underway.

STAT+: Pharmalittle: House Republicans and Democrats du...

House Republicans have drafted drug-shortage legislation that differs significan...

Non-profit receives FDA approval to supply cheaper OTC ...

Harm Reduction Therapeutics won FDA approval for the second OTC naloxone nasal s...